1. Home
  2. EVLV vs PHAT Comparison

EVLV vs PHAT Comparison

Compare EVLV & PHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evolv Technologies Holdings Inc.

EVLV

Evolv Technologies Holdings Inc.

HOLD

Current Price

$6.74

Market Cap

988.3M

Sector

Technology

ML Signal

HOLD

Logo Phathom Pharmaceuticals Inc.

PHAT

Phathom Pharmaceuticals Inc.

HOLD

Current Price

$14.82

Market Cap

942.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVLV
PHAT
Founded
2013
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Computer peripheral equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
988.3M
942.6M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
EVLV
PHAT
Price
$6.74
$14.82
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
5
Target Price
$9.13
$17.60
AVG Volume (30 Days)
3.2M
838.1K
Earning Date
11-13-2025
10-30-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$136,501,000.00
$147,190,000.00
Revenue This Year
$41.14
$218.59
Revenue Next Year
$14.60
$84.38
P/E Ratio
N/A
N/A
Revenue Growth
43.16
460.30
52 Week Low
$2.64
$2.21
52 Week High
$8.91
$16.27

Technical Indicators

Market Signals
Indicator
EVLV
PHAT
Relative Strength Index (RSI) 50.68 55.49
Support Level $6.10 $14.12
Resistance Level $6.85 $16.27
Average True Range (ATR) 0.27 0.72
MACD 0.13 -0.10
Stochastic Oscillator 88.97 29.84

Price Performance

Historical Comparison
EVLV
PHAT

About EVLV Evolv Technologies Holdings Inc.

Evolv Technologies Holdings Inc offers an AI-based touchless security screening. Its touchless security screening systems use artificial intelligence software, cloud services, and sensors to reliably detect dangerous weapons while ignoring harmless items like cell phones, laptops, and keys. It offers products for purchase under a multi-year security-as-a-service subscription pricing model that delivers ongoing value to customers, generates predictable revenue, and creates expansion and upsell opportunities. The firm operates in a single segment that develops, manufactures, markets, and sells security screening products and specific services. Its products are used in different industries such as casinos, industrial workplaces, schools, and ticketed venues.

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

Share on Social Networks: